COSM vs. BIMI, MEDS, ERNA, IMNN, CHRO, CHEK, COEP, DOMH, KPRX, and PPBT
Should you be buying Cosmos Health stock or one of its competitors? The main competitors of Cosmos Health include BIMI (BIMI), TRxADE HEALTH (MEDS), Eterna Therapeutics (ERNA), Imunon (IMNN), Chromocell Therapeutics (CHRO), Check-Cap (CHEK), Coeptis Therapeutics (COEP), Dominari (DOMH), Kiora Pharmaceuticals (KPRX), and Purple Biotech (PPBT). These companies are all part of the "medical" sector.
Cosmos Health (NASDAQ:COSM) and BIMI (NASDAQ:BIMI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability.
Cosmos Health has a net margin of -31.48% compared to BIMI's net margin of -94.58%. Cosmos Health's return on equity of -28.54% beat BIMI's return on equity.
Cosmos Health has a beta of 5.84, meaning that its share price is 484% more volatile than the S&P 500. Comparatively, BIMI has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500.
In the previous week, Cosmos Health had 3 more articles in the media than BIMI. MarketBeat recorded 4 mentions for Cosmos Health and 1 mentions for BIMI. Cosmos Health's average media sentiment score of 0.22 beat BIMI's score of -0.25 indicating that Cosmos Health is being referred to more favorably in the media.
12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 0.1% of BIMI shares are owned by institutional investors. 18.7% of Cosmos Health shares are owned by insiders. Comparatively, 69.0% of BIMI shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
BIMI received 5 more outperform votes than Cosmos Health when rated by MarketBeat users. However, 70.69% of users gave Cosmos Health an outperform vote while only 57.50% of users gave BIMI an outperform vote.
Cosmos Health has higher revenue and earnings than BIMI.
Summary
Cosmos Health beats BIMI on 11 of the 14 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cosmos Health Competitors List
Related Companies and Tools
